Blood-thinning drug linked to heart attack risk

People who take the recently approved blood-thinning medication dabigatran could have a slightly increased risk of heart attack compared with people who use the old standby drug warfarin, new research suggests. Sold under the brand name Pradaxa, dabigatran has been taken by an estimated 500,000 people to prevent blood clots that could cause stroke.

Click here to read more…

0 Responses to “Blood-thinning drug linked to heart attack risk”



  1. Leave a Comment

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s




Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 434 other followers

Contact Us:

Hissey Kientz, LLP

9442 Capital of Texas Hwy N.

Arboretum Plaza One, Suite 400

Austin, Texas 78759

Toll-free: (866) 275-4454

Facsimile: (512) 320-9101

Email: info@hkllp.com

Sponsored By:

Hissey Kientz, LLP (Austin, TX)

Attorney Michael Hissey is responsible for the content of this website.


%d bloggers like this: